[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100460801":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":36,"responsibleParty":52,"collaborators":54,"id":57,"slug":18,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":58,"sex":64,"minAge":65,"maxAge":18,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":18,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Omphis Foundation","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"lymphadenectomy without drainage and with Glubran","EXPERIMENTAL","Application of Glubran 2 in axillary dissection with the objective of seroma reduction. No drain",[13],"Other: Glubran 2",{"label":15,"type":16,"description":17,"interventionNames":18},"Lymphadenectomy without drainage","NO_INTERVENTION","No intervention required, only axillary dissection without drain",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Glubran 2","Application of Glubran 2 sealant (liquid) in axillary hollow",[9],[25],{"name":26,"affiliation":27,"role":28},"Sandra Lopez Gordo, Doctor","Health Consortium Maresme","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"Sandra Lopez Gordo","CONTACT","937 41 77 00","1141","slopezgord@csdm.cat",[37],{"facility":38,"status":39,"city":40,"state":18,"zip":18,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Maresme health consortium","RECRUITING","Mataró","Spain","ES",{"type":44,"coordinates":45},"Point",[46,47],2.4445,41.54211,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":18,"phoneExt":18,"email":18},"Sandra lopez gordo",{"type":28,"investigatorFullName":31,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Principal investigator",[55],{"name":56,"class":6},"Consorci Sanitari del Maresme","100460801",false,"NCT05280353","Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain","Seroma Control in Axillary Lymphadenectomy With Glubran 2® Without Drain. Multicenter, Prospective, Randomized Clinical Trial. GALA-ND Study (Glu Axillary Lymphadenectomy Ambulatory- no Drain)","GALA","Inclusion Criteria:\n\n* Over 18 years old\n* Conservative surgery for breast cancer with associated axillary lymphadenectomy\n\nExclusion Criteria:\n\n* Mastectomy\n* History of axillary surgery or ipsilateral axillary radiotherapy\n* ASA 4 patients. (ASA 3 patients selected)\n* Lack of adequate cognitive capacity and\u002For signed informed consent\n* Pregnancy","FEMALE","18 Years",{"count":67,"type":68},134,"ESTIMATED","INTERVENTIONAL",[71],"NA","Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community. That is why the study was designed to show whether the sealant reduces seroma after axillary lymphadenectomy without drainage.",[74],"Seroma Following Procedure","2024-09-02",{"date":77,"type":78},"2024-09-04","ACTUAL",{"date":80,"type":78},"2022-04-01",{"date":82,"type":68},"2026-06-01",{"name":5,"class":6},1]